{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:06:27Z","timestamp":1774307187923,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K10146"],"award-info":[{"award-number":["16K10146"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of cancers in atopic dermatitis (AD) is not increased, although the Th2-dominant environment is known to downregulate tumor immunity. To gain mechanistic insights regarding tumor immunity in AD, we utilized CCL17 transgenic (TG) mice overexpressing CCL17, which is a key chemokine in AD. Tumor formation and lung metastasis were accelerated in CCL17 TG mice when melanoma cells were injected subcutaneously or intravenously. Flow cytometric analysis showed increases in regulatory T cells (Tregs) in lymph nodes in CCL17 TG mice with high mRNA levels of IL-10 and Foxp3 in tumors, suggesting that Tregs attenuated tumor immunity. The frequency of myeloid-derived suppressor cells (MDSCs), however, was significantly decreased in tumors of CCL17 TG mice, suggesting that decreased MDSCs might promote tumor immunity. Expression of CXCL17, a chemoattractant of MDSCs, was decreased in tumors of CCL17 TG mice. Depletion of Tregs by the anti-CD25 antibody markedly reduced tumor volumes in CCL17 TG mice, suggesting that tumor immunity was accelerated by the decrease in MDSCs in the absence of Tregs. Thus, CCL17 attenuates tumor immunity by increasing Tregs and Th2 cells, while it decreases MDSCs through reductions in CXCL17, which may work as a \u201csafety-net\u201d to reduce the risk of malignant tumors in the Th2-dominant environment.<\/jats:p>","DOI":"10.3390\/ijms22042025","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T20:56:21Z","timestamp":1613681781000},"page":"2025","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis"],"prefix":"10.3390","volume":"22","author":[{"given":"Sohshi","family":"Morimura","sequence":"first","affiliation":[{"name":"Department of Dermatology, International University of Health and Welfare, Chiba 286-8520, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-329X","authenticated-orcid":false,"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[{"name":"Department of Dermatology, International University of Health and Welfare, Chiba 286-8520, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-3207","authenticated-orcid":false,"given":"Tomonori","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Suga","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-3128","authenticated-orcid":false,"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St. Marianna University School of Medicine, Kanagawa 216-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-6489","authenticated-orcid":false,"given":"Yuichiro","family":"Tsunemi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-9778","authenticated-orcid":false,"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0091-6749(84)80008-1","article-title":"Atopic dermatitis","volume":"73","author":"Hanifin","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.18176\/jiaci.0519","article-title":"A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis","volume":"30","author":"Nettis","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ijc.11054","article-title":"Atopic disease and childhood acute lymphoblastic leukemia","volume":"105","author":"Morgan","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1008958724739","article-title":"Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States)","volume":"11","author":"Wen","year":"2000","journal-title":"Cancer Causes Control."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P","article-title":"Role of medical history in brain tumour development. Results from the international adult brain tumour study","volume":"82","author":"Schlehofer","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.10320","article-title":"History of allergies and autoimmune diseases and risk of brain tumors in adults","volume":"99","author":"Brenner","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1011274922701","article-title":"Environmental risk factors for non-Hodgkin\u2019s lymphoma: A population-based case-control study in Languedoc-Roussillon, France","volume":"12","author":"Daures","year":"2001","journal-title":"Cancer Causes Control."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00051358","article-title":"Leukemia, lymphoma, and multiple myeloma following selected medical conditions","volume":"3","author":"Doody","year":"1992","journal-title":"Cancer Causes Control."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0145-2126(98)80012-X","article-title":"Non-hodgkin\u2019s lymphoma: Case control epidemiological study in Yorkshire","volume":"12","author":"Cartwright","year":"1988","journal-title":"Leuk. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2016.07.009","article-title":"Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis","volume":"84","author":"Gandini","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a higly specific biological ligand for C chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activa-tion-regulated chemokine (TARC\/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1398-9995.2002.5720256.x","article-title":"Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics","volume":"57","author":"Sekiya","year":"2002","journal-title":"Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/ajrccm.165.8.2106110","article-title":"Elevated levels of thymus-and actication-regulated chemokine in brochoalveolar lavage fluid from patients with eosinophilic pneumonia","volume":"165","author":"Miyazaki","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-016-0729-9","article-title":"Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma","volume":"33","author":"Zhu","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer","volume":"122","author":"Mizukami","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-07-0472","article-title":"A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment","volume":"13","author":"Strauss","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer","volume":"182","author":"Sinha","year":"2009","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/eji.200535564","article-title":"CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli","volume":"36","author":"Tsunemi","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2249.2005.02989.x","article-title":"Regulation of local and metastatic host-mediated anti-tumour mechanisms by l-selectin and intercellular adhesion molecule-1","volume":"143","author":"Yamada","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-019-1114-3","article-title":"CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB","volume":"21","author":"Hsu","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Li, L., Yan, J., Xu, J., Liu, C.-Q., Zhen, Z.-J., Chen, H.-W., Ji, Y., Wu, Z.-P., Hu, J.-Y., and Zheng, L. (2014). CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110064"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/bjc.2016.4","article-title":"Ectopic expression of the chemokine CXCL17 in colon cancer cells","volume":"114","author":"Ohlsson","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4166\/kjg.2018.71.1.38","article-title":"Association be-tween Atopic Dermatitis and Risk of Gastric Cancer: A Nationwide Population-based Study","volume":"71","author":"Jo","year":"2018","journal-title":"Korean J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1158\/1055-9965.EPI-05-0119","article-title":"Allergies and the Risk of Pancreatic Cancer: A Meta-analysis with Review of Epidemiology and Biological Mechanisms","volume":"14","author":"Gandini","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1948050","article-title":"Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4","volume":"254","author":"Golumbek","year":"1991","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: A review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.07.007","article-title":"Erythrodermic cutaneous T-cell lymphoma: How to differentiate this rare disease from atopic der-matitis","volume":"64","author":"Miyagaki","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.12788\/cutis.0074","article-title":"Long-standing dermatitis treated with dupilumab with subsequent pro-gression to cutaneous T-cell lymphoma","volume":"106","author":"Hollins","year":"2020","journal-title":"Cutis"},{"key":"ref_35","unstructured":"Harvey, M. (1994). Prism, Version 7, GraphPad."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/2025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:53Z","timestamp":1760160353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22042025"],"URL":"https:\/\/doi.org\/10.3390\/ijms22042025","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}